Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 19 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INTERLEUKIN GENETICS INC | 55,418,811 | reported | 29 Jul 2016 | tx 4+79,979,378 |
| AVEO PHARMACEUTICALS INC | 25,243,865 | reported | 08 Apr 2019 | tx 28+19,228,998 |
| Millennial Media Inc. | 8,196,614 | reported | 29 Oct 2012 | tx 4+9,794,401−11,392,188 |
| GENOCEA BIOSCIENCES, INC. | 7,225,676 | reported | 24 Jun 2019 | tx 3+15,292,478 |
| Roka BioScience, Inc. |
| 5,714,286 |
| reported |
| 21 Sept 2016 |
| tx 12+8,934,362−30,933,900 |
| Achaogen Inc | 5,215,128 | reported | 19 Dec 2016 | tx 1+500,000 |
| AEROHIVE NETWORKS, INC | 4,673,589 | reported | 02 Apr 2014 | tx 3+4,653,589−4,653,589 |
| Trevi Therapeutics, Inc. | 4,438,562 | reported | 09 May 2019 | tx 4+4,438,562−17,099,315 |
| Mirna Therapeutics, Inc. | 4,228,940 | reported | 26 Jan 2018 | tx 9+6,775,956−1,825,209 |
| Elastic N.V. | 4,155,995 | reported | 10 Oct 2018 | tx 4+5,684,112−5,684,112 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | PURCHASE | ARDELYX, INC. | 333,333 | 5.84 USD | |
| 06 Jan 2026 | TENDER | Mersana Therapeutics, Inc. | 383 | — | |
| 06 Jan 2026 | TENDER | Mersana Therapeutics, Inc. | 23,546 | — | |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 181 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,002 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 740 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,800 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 734 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 2,200 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 368 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 788 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,000 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,011 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 400 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 2,460 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 264 | — | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 18,884 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 28,326 | 6.42 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 31,163 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 41,551 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 54,059 | 0.00 USD | deriv |
| 16 Jun 2025 | PURCHASE | ARDELYX, INC. | 200,000 | 3.63 USD | |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Mersana Therapeutics, Inc. | 61,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Nov 2024.